Delivery Order SPE2DB20D2014-SPE2DB24FC98Q
Award Date
9/10/24
Potential Completion Date
10/1/24
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $4,711.62 to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of PROQUAD VIALS, a vaccine product, with a period of performance through July 5, 2024. This delivery order falls under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025....
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,568,112,338 vials of the PROQUAD vaccine. The total ceiling value of the contract is $3,308.68, with a period of performance through May 21, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp, the Corporate Office Division of Amerisourcebergen Corporation, for the supply of PROQUAD VIALS medical products. The contract has a ceiling value of $1,570.54 and a completion date of May 23, 2024. This award is issued under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of 4,565,833,079 units of PROQUAD vaccine vials. The $3,203.98 firm fixed price contract has an ultimate completion date of October 2, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 between AmerisourceBergen and DLA Troop Support Medical for the comprehensive supply of pharmaceutical and medical...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of PROQUAD VIALS. The contract has a ceiling value of $1,601.99 and a period of performance through April 11, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply PROQUAD VIALS. The contract has a potential value of $4,805.97 and a completion date of March 19, 2024. This delivery order is part of an Indefinite Delivery Contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The...
The U.S. government agency Defense Logistics Agency (DLA) awarded a $3,141.08 firm-fixed price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide PROQUAD VIALS. The contract has an ultimate completion date of August 21, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical to deliver a comprehensive range of medical commodities in support...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of 4,564,821,936 doses of the PROQUAD vaccine. The $11,187.81 firm-fixed price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, which provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. Amerisourcebergen holds a larger single-award Indefinite Delivery Contract (IDC) with the DLA, valued at up...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of PROQUAD vaccine vials. The contract has a ceiling value of $6,407.96 and a completion date of May 31, 2024. It is a firm fixed-price contract with no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025....
This is a $4,711.62 firm-fixed-price delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of 4,564,483,817 PROQUAD VIALS, with a completion date of May 23, 2024. The awarding agency is the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government...